Immunoassays: Page 2

Amid overdose epidemic, NIH and FDA seeking to reduce barriers to rapid drug-detection tools

By LabPulse.com staff writers

The rapid detection tools often remain inaccessible because of gaps in research and other barriers, including state or legal prohibitions.

June 12, 2023

Quantification of long COVID fatigue shows impact is worse than some cancers

By Nick Paul Taylor

Fatigue is the most impactful symptom in the lives of people suffering from long COVID, with patients reporting worse scores than individuals with some cancers.

June 8, 2023

Seegene obtains IVDR certification for 30 diagnostic assays

By LabPulse.com staff writers

The newly certified assays include eight for gastrointestinal infections, seven for women's diseases, five for respiratory diseases, four for tuberculosis, three for meningitis, two for human papillomavirus (HPV), and one for drug resistance.

June 1, 2023

Serum assay may enable the diagnosis of neurodegenerative diseases

By Elissa Wolfson

An assay that detects minute concentrations of alpha synuclein seeds in blood serum may enable quicker diagnosis of neurodegenerative disorders.

May 30, 2023

Romanian IVD market worth watching, rose to $464M in 2022

By Bruce Carlson

The Eastern European country's IVD market will grow 25% faster than that of the United States, according to Kalorama Information in its latest 30-Country IVD Market Atlas.

May 31, 2023

Malaria rapid tests in study show low performance for travelers to China

By LabPulse.com staff writers

The study evaluated the sensitivity of four parasite enzyme lactate dehydrogenase-targeting RDTs and one aldolase-targeting RDT for P. malariae detection.

May 25, 2023

Antibody titer levels associated with protection against Omicron: Study

By Elissa Wolfson

Immunoglobin G and neutralizing antibody titer levels were associated with protection against infection with the Omicron variant and against symptomatic disease.

May 23, 2023

Beckman Coulter analyzer developed 'from the ground up' to address IVD industry constraints

By Leo O'Connor

At a time of scarce resources, the system requires no daily maintenance and only 10 minutes weekly and monthly maintenance, said Dr. Pamela Christudoss of Christian Medical College, who evaluated the analyzer prior to its broad launch last week.

May 23, 2023

Thermo Fisher Scientific obtains FDA clearance for preeclampsia risk immunoassays

By LabPulse.com staff writers

The new assays are the first and only such immunoassays to receive breakthrough designation and clearance for preeclampsia risk assessment and management, the company noted in a statement.

May 19, 2023

Zymo Research, Burst Diagnostics partner to develop, commercialize hand-held diagnostic testing platform

By LabPulse.com staff writers

The device leverages a microfluidic cartridge that miniaturizes and integrates steps typically performed in the clinical laboratory setting, including washing and signal amplification, Zymo Research said.

May 18, 2023

Running stool test twice increases colon cancer detection rate in clinical trial

By Nick Paul Taylor

The fecal immunochemical test can deliver false negatives that may delay further investigations and the diagnosis and treatment of colorectal cancer. To try to raise the sensitivity, researchers explored the effects of testing twice.

May 18, 2023

At WorldLab-EuroMedLab 2023, Roche to demonstrate next-gen Dx, mass spec for routine testing

By LabPulse.com staff writers

The company will unveil the Cobas Mass Spec system prototype, which aims to bring mass spectrometry to routine testing and complement the serum work area testing portfolio.

May 17, 2023

Previous Page

Page 2 of 61

Next Page